Mesenchymal Stem Cell Therapy for Aging Frailty
Chronic diseases and degenerative conditions are strongly linked with the geriatric syndrome of frailty and account for a disproportionate percentage of the health care budget. Frailty increases the risk of falls, hospitalization, institutionalization, disability, and death. By definition, frailty s...
Main Authors: | Ivonne Hernandez Schulman, Wayne Balkan, Joshua M. Hare |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-11-01
|
Series: | Frontiers in Nutrition |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnut.2018.00108/full |
Similar Items
-
Mesenchymal Stem Cell Secretion of SDF-1α Modulates Endothelial Function in Dilated Cardiomyopathy
by: Courtney Premer, et al.
Published: (2019-09-01) -
Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells
by: Courtney Premer, et al.
Published: (2015-05-01) -
Allogeneic mesenchymal stem cell therapy: A regenerative medicine approach to geroscience
by: Anthony A. Oliva, et al.
Published: (2019-09-01) -
Stem cells: Role in medical and dental therapies
by: Sumit Bhateja
Published: (2012-01-01) -
Stem Cell Therapy for Acute/Subacute Ischemic Stroke with a Focus on Intraarterial Stem Cell Transplantation: From Basic Research to Clinical Trials
by: Susumu Yamaguchi, et al.
Published: (2022-12-01)